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Highlight 
✓ Anamnesis and detailed clinical examination are 
essential for the prevention and treatment of oral 
cancer (OC). 
✓ Basic knowledge in oral pathology is a requirement 
for all dental surgeons, as well as being always 
attentive to the detailed clinical examination. 
✓ Perform biopsies whenever you notice tissue 
changes older than 15 days that have not healed. 
✓ OC represents the 6th most common cancer in the 
world, with approximately 90% being represented by 
squamous cell carcinoma, and 10% represented by 
mesenchymal neoplasms (malignant neoplasm of 
cartilage tissue and salivary glands). 
✓ The prevention of OC depends mainly on the 
elimination of risk factors involved in its 
etiopathogenesis. 
✓ Every dental surgeon must emphasize and clarify the 
importance of self-examination to the patient. 
✓ The main causes are tobacco, alcohol, poor oral 
hygiene, residual roots, local irritation, sun exposure. 
Abstract 
Introduction: Oral cancers (OC) represent more than 
90% of cases. It is estimated that more than 400,000 
new cases of oral cancer are diagnosed each year 
worldwide. OC is preventable as most of the different 
identified risk factors, such as tobacco use, alcohol 
consumption, and betel nut chewing, are behaviors that 
increase the likelihood of the disease. Surgical biopsy 
remains the gold standard, but adjunctive tools have 
been developed to aid diagnoses, such as vital toluidine 
blue staining and autofluorescence imaging. 
Objective: To emphasize and present the importance 
of the dental surgeon in the early diagnosis and 
prevention of oral cancer. Methods: The survey was 
 
 
conducted from July 2021 to August 2021 and 
developed based on Scopus, PubMed, Science Direct, 
Scielo, and Google Scholar, following the rules of 
Systematic Review-PRISMA. Study quality was based on 
the GRADE instrument and the risk of bias was analyzed 
according to the Cochrane instrument. Results: Early 
detection and treatment of OC were found to be 
important predictors for improving survival and 
reducing mortality. A thorough clinical inspection of the 
oral cavity can detect up to 99% of oral cancers. Other 
diagnostic types have been developed to help overcome 
the limits of standard oral clinical examination, 
highlighting toluidine blue staining, light-based 
detection techniques, and salivary biomarkers. Self-
examination is an effective strategy to reduce the levels 
of mortality and morbidity caused by this pathology. A 
gain of 8.09% more in sensitivity and 11.36% more in 
specificity was observed with the fluorescence test. 
Conclusion: The findings clearly showed that early 
diagnosis of oral cancer is essential to increase the 
chances of cure and survival of patients, avoiding 
invasive surgical intervention. Currently, there are 
several diagnostic tools for screening and visual devices 
for the early detection of oral lesions through auxiliary 
methods, logically maintaining biopsy as the gold 
standard. 




Oral cancers (OC) represent more than 90% of 
cases [1]. Other examples of oral tumors include those 
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lymphomas [2]. It is estimated that more than 400,000 
new cases of oral cancer are diagnosed each year in the 
world, with 2/3 of the cases occurring in Asian countries 
[1,3]. In Westerners, on the other hand, OC is 
infrequent. In this context, despite the epidemiological 
data, OC is preventable, since most of the different risk 
factors identified, such as tobacco use, alcohol 
consumption, and chewing betel nut, are behaviors that 
increase the probability of the disease. Thus, 
anticipating the diagnosis begins with the identification 
of potentially malignant lesions of the oral mucosa and 
inflammatory processes [4]. 
In this sense, clinical recognition and evaluation of 
lesions of the oral mucosa can detect up to 99% of 
cancers. According to WHO, the lesion needs to 
disappear within two weeks and must be biopsied. 
Surgical biopsy remains the gold standard for diagnosing 
oral cancer. Additionally, adjunctive tools have been 
developed to aid diagnoses, such as vital toluidine blue 
staining and autofluorescence imaging [4]. 
Oral cancer can be easily detected through 
relatively simple tests, and the prognosis of the disease 
is linked to the stage at which it is detected. Visualization 
of the OC is facilitated by the anatomical characteristics 
and by the location of the oral cavity, to dispense with 
the use of instruments of high technological complexity 
and hardly generate discomfort for the patient. Hence 
the importance of professional awareness for early 
diagnosis and the correct direction for treatment [5,6]. 
In this context, the etiology of OC is multifactorial, 
resulting from several factors that predispose to the 
development of this pathology, with a high incidence 
and mortality, and is among the 10 most common 
pathologies in the world [5]. The areas that suffer most 
from the disease are the tongue, specifically the 
posterior lateral border, mouth floor, gums, mucosa, 
tonsils, retromolar region, dorsum of the tongue, soft 
palate, and hard palate [5]. The survival rate of early 
diagnosis in the early stages ranges from 53% to 68%, 
while the diagnosis of advanced cancer is approximately 
41% and 27% and in the late stage, it is regrettably 70 
to 80% [6]. 
In this scenario, the most common type (94% to 
96% of cases) of oral cancer is squamous cell carcinoma 
(SCC) or squamous cell carcinoma that affects the most 
common sites of this pathology are the tongue (26%) 
and the lower lip (23 %) [6,7]. Furthermore, OC was 
divided into categories such as salivary gland tumors, 
epithelial tumors, mesenchymal tumors, bone tumors, 
hematological tumors, odontogenic tumors, and others 
[7]. In this aspect, the dentist is the health professional 
who has an important role in the actions and a strategic 
role [8]. 
Therefore, this work aimed to highlight and present 
the importance of the dental surgeon in the early 




The rules of the Systematic Review Platform-
PRISMA (Transparent report of systematic reviews and 
meta-analysis-HTTP: //www.prisma-statement.org/) 
were followed [9]. 
 
Research Strategy 
The search strategies for this systematic review 
were based on the keywords (MeSH Terms): “Oral 
cancer; Prevention; Early diagnosis; Auxiliary 
techniques”. The survey was conducted from July 2021 
to August 2021 and was developed based on Scopus, 
PubMed, Science Direct, Scielo, and Google Scholar. In 
addition, a combination of the keywords with the 
Booleans "OR", "AND", and the operator "NOT" were 
used. 
 
Study Quality and Risk of Bias 
The quality of the studies was based on the GRADE 
instrument [10] and the risk of bias was analyzed 
according to the Cochrane instrument [11]. Two 
independent reviewers performed the research and 
study selection. Data extraction was performed by 
reviewer 1 and fully reviewed by reviewer 2. A third 
investigator decided on some conflicting points and 
made the final decision to choose the articles. 
 
Results and Discussion 
A total of 315 articles were found on oral cancer 
and early diagnosis. Initially, duplication of articles was 
excluded. After this process, the abstracts were 
evaluated and a new exclusion was performed, 
removing the articles that did not address the theme of 
this article. In total, 85 articles were fully evaluated and 
26 were included and evaluated in this study (Figure 
1). 
Considering the Cochrane tool for risk of bias, the 
overall assessment in 3 studies with a high risk of bias 
and 2 studies with uncertain risk. The domains that 
presented the highest risk of bias were related to the 
number of participants in each study, and the uncertain 
risk was related to the safety and efficacy of early 
diagnosis and auxiliary techniques. Also, there was no 
funding source in the 2 studies and 1 study did not 
disclose information about the declaration of conflict of 
interest. 
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After a restricted analysis of the studies, it was 
identified that the early detection and treatment of OC 
are important predictors to improve survival and reduce 
mortality [12]. The diagnostic process begins with a 
clinical oral examination, with visual inspection and 
digital palpation [13,15]. A thorough clinical inspection 
of the oral cavity can detect up to 99% of oral cancers 
[12]. 
In this context, in the initial period, the OC can be 
asymptomatic. It is necessary to identify persistent 
mouth sores and/or pain, localized changes in the 
appearance of the oral mucosa, localized changes in the 
consistency of the oral mucosa, persistent white or red 
spots or mixed white and red spots of the oral mucosa, 
raised spot or plaque on the oral mucosa, lump or 
persistent growth in the oral mucosa, a bleeding area 
located in the oral mucosa as proposed by the World 
Health Organization and the National Institute of Dental 
and Craniofacial Research and the American Dental 
Association [15]. 
In this sense, the routine cytological examination 
of a smear collected from the epithelial surface of the 
oral mucosa has low sensitivity and specificity to serve 
as a predictive diagnostic tool for squamous cell 
carcinoma. Also, brush biopsy and micro biopsy have 
been proposed [16]. Besides, other types of diagnosis 
have been developed to help overcome the limits of the 
standard oral clinical examination [12], highlighting 
toluidine blue staining, light-based detection techniques, 
and salivary biomarkers [17]. 
 
Main Auxiliary Techniques and Diagnostic 
Practices 
Toluidine Blue 
Toluidine blue (TB) staining is a simple, inexpensive, 
and non-invasive technique to guide the diagnosis of 
malignant and premalignant lesions [18]. TB is a 
cationic metachromatic dye that chemically binds to the 
dysplastic epithelium (turning blue) [17]. In this sense, 
an aqueous solution at 1% v/v is applied for 30 seconds 
in the area of the suspected lesion, after the application 
of acetic acid at 1% v/v to remove the salivary and 
bacterial film [17]. 
 
Autofluorescence Imaging 
Autofluorescent imaging can provide additional 
Records identified through database 



































Additional records identified through 
other sources (n = 10) 
Total = 315 articles; Duplicates removed (n = 25) 
Records screened 
(n = 290) 
Articles excluded 
(n = 121) 
Articles assessed for 
eligibility 
(n = 169) 
Articles excluded 
(n = 84) 
Studies included in 
qualitative synthesis 
(n = 85) 
Systematic Review 
(n = 26) 
Articles excluded 
(n = 59) 
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information about the nature of the lesion [19], being 
an adjunct to visual and tactile clinical examination [20]. 
 
Salivary Biomarkers 
Human saliva presents organic and inorganic 
molecules, proteins, peptides, and electrolytes, 
representing more than 100 biomarkers [21-23], 
pointing to pathological predictors such as viruses, 
cytokines (IL-1b, IL-8, TNF-α), receptors protein (CD44) 
[23,24], and DNA and RNA markers [23-25]. 
Also, self-examination is an effective strategy in 
reducing the levels of mortality and morbidity caused by 
this pathology, making clear the importance of health 
education in improving people's living conditions [1]. 
The dentist discloses the information, in addition to 
providing guidance, encouraging self-examination so 
that it can be diagnosed early, facilitating preventive 
work, thus giving the chance of cure [1,2]. 
Added to this, a study found that OC caused by 
chewing betel nuts has a poor prognosis. Thus, this 
study evaluated a Health Belief Model intervention using 
a lay health counselor (LHAs) for OC screening and 
mouth self-examination (MSE) in Aboriginal 
communities. Intervention (IG; n = 171) and control 
(CG; n = 176) groups. Participants in the IG were 2.04 
times more likely to perform a monthly MSE than those 
in the CG and showed significantly higher levels of self-
efficacy for CO and MSE [26]. 
Besides, a study with 98 patients (n = 49/group) 
evaluated the usefulness of a portable autofluorescence 
device (OralID) to detect oral premalignant lesions. The 
positive potential malignant lesions (PMLs) observed in 
the group without the use of OralID were 89.47% when 
compared with biopsies, while in the group with OralID 
it was 95.24%. Thus, a gain of 8.09% more sensitivity 
and 11.36% more specificity was observed with the 
OralID fluorescence test [27]. 
In addition, a study compared the quality of two 
different cell harvesting techniques. Thus, cell smears 
were collected from 10 orally healthy individuals from 
the palatal mucosa at two different times, baseline and 
4 weeks later. The slides from both techniques were 
stained by Giemsa (n=40) and May-Gruenwald Giemsa 
(n=40). Liquid-based cytology showed statistically 
significant improvement compared to conventional glass 
sides. The thin layers, which were performed by liquid-
based cytology, showed significantly better results in 
parameters such as uniform distribution, cell overlap, 
cell deformation, mucus, microbial colonies, and debris. 
The conventional glass slide approach showed more cell 
overlap and foreign material contamination than thin 
layers, which were performed by Orcellex® Brush cell 
collectors [28]. 
Also, a study evaluated 376 cases of odontogenic 
tumors from an oral pathology service regarding age, 
sex, anatomical location, and histological diagnosis. 
Keratocystic odontogenic tumors (31.6%) were the 
most common, followed by ameloblastoma (28.5%) and 
odontoma (22.6%). The mean age was 32.2 years, and 
more than half of the patients (52.1%) were in their 
second and third decades of life. The male/female ratio 




The findings clearly showed that early diagnosis of 
oral cancer is essential to increase the chances of cure 
and survival of patients, avoiding invasive surgical 
intervention. Currently, there are several diagnostic 
tools for screening and visual devices for the early 
detection of oral lesions through auxiliary methods, 
logically maintaining biopsy as the gold standard. 
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